Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Calcifediol

    Client Email Product

    Calcifediol

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    12
    US DMFs Filed

    US DMFs Filed

    4
    CEP/COS Certifications

    CEP/COS Certifications

    4
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    7
    API REF. PRICE (USD / KG)
    443,847

    API Market Place

    2
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    3
    Europe

    Europe

    1
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    173.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    77
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    22

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    16
    REF STANDARD

    EDQM

    2

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    Full View ScreenFull Screen View
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023

    https://www.globenewswire.com//news-release/2023/11/02/2772514/0/en/New-Clinical-Data-on-OPKO-Health-s-RAYALDEE-ER-Calcifediol-Presented-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023

    https://www.globenewswire.com//news-release/2023/10/25/2766975/0/en/OPKO-Health-to-Present-New-Clinical-Data-on-Rayaldee-ER-Calcifediol-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP

    https://www.globenewswire.com/news-release/2022/02/03/2378541/0/en/RAYALDEE-Launched-in-Germany-by-OPKO-Health-s-Licensee-VFMCRP.html

    GLOBENEWSWIRE
    03 Feb 2022
    Share Share
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee

    https://trialsitenews.com/opko-health-announces-topline-data-from-phase-2-trial-of-rayaldee-in-treating-mild-to-moderate-covid-19-supporting-the-use-of-vitamin-d-repletion-therapy/

    TRIALSITENEWS
    24 Dec 2021
    Share Share
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142236&sid=2

    PHARMABIZ
    01 Sep 2021
    Share Share
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients

    https://www.globenewswire.com/news-release/2021/08/30/2288690/0/en/OPKO-Health-Completes-Enrollment-in-Phase-2-Trial-Evaluating-RAYALDEE-as-a-Treatment-for-Symptomatic-COVID-19-Outpatients.html

    GLOBENEWSWIRE
    30 Aug 2021
    Share Share
    OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
    OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients

    https://www.biospace.com/article/releases/opko-health-initiates-clinical-trial-of-rayaldee-in-covid-19-patients/

    BIOSPACE
    15 Sep 2020
    Share Share
    OPKO receives US FDA approval to begin phase 2 trial with Rayaldee
    OPKO receives US FDA approval to begin phase 2 trial with Rayaldee

    http://www.pharmabiz.com/NewsDetails.aspx?aid=126557&sid=2

    PHARMABIZ
    02 Jun 2020
    Share Share
    FDA Authorizes OPKO Health Trial Evaluating RAYALDEE in COVID-19 Patients
    FDA Authorizes OPKO Health Trial Evaluating RAYALDEE in COVID-19 Patients

    https://www.opko.com/news-media/press-releases/detail/394/fda-authorizes-opko-health-clinical-trial-evaluating

    OPKO
    02 Jun 2020
    Share Share
    FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19
    FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19

    https://www.globenewswire.com/news-release/2020/06/01/2041443/0/en/FDA-Authorizes-OPKO-Health-Clinical-Trial-Evaluating-RAYALDEE-in-COVID-19-Patients.html

    GLOBENEWSWIRE
    01 Jun 2020
    Share Share
    Global Calcifediol Monohydrate Market 2020
    Global Calcifediol Monohydrate Market 2020

    https://www.bccourier.com/global-calcifediol-monohydrate-market-2020-strategic-assessment-by-top-players-like-dishman-group-chemvon-biotechnology-co/

    BCCOURIER
    14 Mar 2020
    Share Share
    FDA to drugmakers: Don't let manufacturing lead to rejection
    FDA to drugmakers: Don't let manufacturing lead to rejection

    http://www.biopharmadive.com/news/fda-to-drugmakers-dont-let-manufacturing-lead-to-rejection/433438/

    Ned Pagliarulo BIOPHARMADIVE
    05 Jan 2017
    Share Share
    OPKO Announces U.S. Launch of RAYALDEE™
    OPKO Announces U.S. Launch of RAYALDEE™

    https://globenewswire.com/news-release/2016/11/23/892452/0/en/OPKO-Announces-U-S-Launch-of-RAYALDEE.html

    GLOBENEWSWIRE
    23 Nov 2016
    Share Share
    FDA Rejects Sanofi-Regeneron Arthritis Drug Over Plant Deficiencies
    FDA Rejects Sanofi-Regeneron Arthritis Drug Over Plant Deficiencies

    http://www.wsj.com/articles/fda-rejects-sanofi-regeneron-arthritis-drug-over-plant-deficiencies-1477685147

    Maria Armental WALL STREET
    29 Oct 2016
    Share Share
    OPKO Health's Calcifediol Approved in US for Secondary Hyperparathyroidism
    OPKO Health's Calcifediol Approved in US for Secondary Hyperparathyroidism

    https://www.pharmacompass.com/pdf/news/opko-healths-calcifediol-approved-in-us-for-secondary-hyperparathyroidism-1467005945.pdf

    FDA
    17 Jun 2016
    Share Share
    Opko Health (OPK) Falls as the FDA Halts Approval of Rayaldee
    Opko Health (OPK) Falls as the FDA Halts Approval of Rayaldee

    http://www.biospace.com/News/opko-health-falls-as-the-fda-halts-approval-of/413751/source=TopBreaking

    BIOSPACE
    30 Mar 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search